Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 23332898)

1.

Predictors of long-term high on-treatment platelet reactivity in clopidogrel-treated patients undergoing coronary stenting for acute coronary syndrome.

Cuisset T, Quilici J, Morange PE, Bonnet JL, Alessi MC.

Int J Cardiol. 2013 Sep 30;168(2):1565-6. doi: 10.1016/j.ijcard.2012.12.062. Epub 2013 Jan 17. No abstract available.

PMID:
23332898
2.

Poverty, development and cardiovascular trials: more questions than answers?

Banerjee A.

Heart. 2015 Feb;101(4):245-7. doi: 10.1136/heartjnl-2014-306946. Epub 2014 Dec 23. No abstract available.

PMID:
25538135
3.

Reply to the editor.

Mannacio V, Meier P, Antignano A, Di Tommaso L, De Amicis V, Vosa C.

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1762-3. doi: 10.1016/j.jtcvs.2014.05.030. No abstract available.

PMID:
25260285
4.

How to optimize an individualized strategy for antiplatelet drug administration and discontinuation management using platelet function testing?

Burcar I, Biocina B, Bulum J, Petricevic M.

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1761-2. doi: 10.1016/j.jtcvs.2014.05.011. No abstract available.

PMID:
25260283
5.

Reply: To PMID 24130971.

Jayasinghe R.

Aust Fam Physician. 2014 Aug;43(8):503. No abstract available.

PMID:
25252367
6.

Interaction between clopidogrel and smoking.

Mendelsohn C.

Aust Fam Physician. 2014 Aug;43(8):503. No abstract available.

PMID:
25252366
7.

Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes.

Berent R, Berent T, Karkutli E, Sinzinger H.

Am J Cardiol. 2014 Oct 1;114(7):1128-9. doi: 10.1016/j.amjcard.2014.07.003. Epub 2014 Jul 16. No abstract available.

PMID:
25212554
8.

[Antiplatelet drugs].

Nishikawa M.

Nihon Rinsho. 2014 Jul;72(7):1248-53. Review. Japanese.

PMID:
25163316
9.

[Acute coronary syndrome].

Thiele H.

Herz. 2014 Sep;39(6):667. doi: 10.1007/s00059-014-4135-9. German. No abstract available.

PMID:
25062718
10.

Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?

Schühlen H.

Eur Heart J. 2014 Aug 14;35(31):2055-7. doi: 10.1093/eurheartj/ehu202. Epub 2014 Jun 20. No abstract available.

PMID:
24950694
11.

Serial clopidogrel dose adjustment after platelet function testing improves outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention with high on-treatment platelet reactivity.

Samardzic J, Krpan M, Skoric B, Pasalic M, Petricevic M, Milicic D.

J Thromb Thrombolysis. 2014 Nov;38(4):459-69. doi: 10.1007/s11239-014-1087-0.

PMID:
24853829
12.

Prediction of bleeding in patients with acute coronary syndromes: applying the new BARC definition.

Ariza-Solé A, Ferreiro JL, Sánchez-Salado JC, Lorente V, Salazar-Mendiguchía J, Nato M, Di Marco A, Gomez-Hospital JA, Cequier Á.

Thromb Res. 2014 May;133(5):952-4. doi: 10.1016/j.thromres.2014.02.019. Epub 2014 Feb 24. No abstract available.

PMID:
24613696
13.

A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Dasbiswas A, Rao MS, Babu PR, Vijayvergiya R, Nayak R, Dani S, Tyagi S, Hiremath S, Patel T, Alexander T, Prakash VS, Singh DP, Yadav MK, Pathak K, Srivastava A.

J Assoc Physicians India. 2013 Feb;61(2):114-6, 126.

PMID:
24471250
14.

Potential clinical utility of genetic and platelet function tests in patients on treatment with clopidogrel.

Cattaneo M.

J Cardiovasc Med (Hagerstown). 2013 Dec;14 Suppl 1:S16-21. doi: 10.2459/JCM.0b013e328364bd3a. Review.

PMID:
24378837
15.

The enigmatic search for optimal DAPT duration.

Gurbel PA, Mahla E, Tantry US.

Eur Heart J. 2014 Apr;35(15):951-4. doi: 10.1093/eurheartj/eht487. Epub 2013 Nov 24. No abstract available.

16.

Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome.

Zhang YY, Zhou X, Ji WJ, Shi R, Lu RY, Li JL, Yang GH, Luo T, Zhang JQ, Zhao JH, Jiang TM, Li YM.

J Thromb Thrombolysis. 2014 Jul;38(1):65-72. doi: 10.1007/s11239-013-1022-9.

PMID:
24202700
17.

Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting.

Pankert M, Quilici J, Loundou AD, Verdier V, Lambert M, Deharo P, Bonnet G, Gaborit B, Morange PE, Valéro R, Dutour A, Bonnet JL, Alessi MC, Cuisset T.

Am J Cardiol. 2014 Jan 1;113(1):54-9. doi: 10.1016/j.amjcard.2013.09.011. Epub 2013 Oct 4.

PMID:
24182762
18.

Mean platelet volume in patients undergoing percutaneous coronary intervention.

Balta S, Mikhailidis DP, Kurtoglu E, Demirkol S.

Platelets. 2015;26(3):269-70. doi: 10.3109/09537104.2013.842207. Epub 2013 Oct 31. No abstract available.

PMID:
24175574
19.

Clopidogrel results in favourable changes in nitric oxide metabolism in patients undergoing percutaneous coronary intervention.

Bundhoo S, Sagan E, James PE, Anderson RA.

Thromb Haemost. 2014 Feb;111(2):373-4. doi: 10.1160/TH13-05-0394. Epub 2013 Oct 24. No abstract available.

PMID:
24154807
20.

New antiplatelet agents and the role of platelet function testing in acute coronary syndromes.

Sinhal AR, Aylward PE.

Clin Ther. 2013 Aug;35(8):1064-8. doi: 10.1016/j.clinthera.2013.07.429. Review.

PMID:
23973039
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk